Manhattan Hematology Oncology Center — New York, New York

Manhattan Hematology Oncology Center is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Manhattan Hematology Oncology Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Follicular Lymphoma.

Sponsors: Xynomic Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Manhattan Hematology Oncology Center?

Manhattan Hematology Oncology Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Manhattan Hematology Oncology Center conducted?

Manhattan Hematology Oncology Center has 1 clinical trials on record, with 1 currently active. Their work covers Follicular Lymphoma.

Is Manhattan Hematology Oncology Center accredited by Crixeo Health?

Manhattan Hematology Oncology Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Manhattan Hematology Oncology Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.